Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Edessa
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Edessa: September 2026
vs
Verdict76/ 100
Grade C · #72Edessa
Clean three-rung tables one click in, behind a homepage whose three cards all quote six-month rungs and whose cheapest is a different drug.
Visit EdessaThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 76/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Edessa still earns its place — a six-month committer, or anyone willing to click past the homepage to the table that states the real monthly rate.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results80
92
Real-world results80
97Price honesty64
97
Price honesty64
96Prescriber access80
96
Prescriber access80
88Formulary choice80
88
Formulary choice80
95Cancellation fairness74
95
Cancellation fairness74
93Member support82
93
Member support82
Price, coverage & features
| Metric | CoreAge Rx | Edessa |
|---|---|---|
| Verdict Score | 94/100 | 76/100 |
| Grade | A | C |
| Semaglutide | $99/mo | $179/mo injectable (compounded; $135 only on a 6-month prepay) |
| Tirzepatide | $149/mo | $239/mo (compounded; $209 only on a 6-month prepay) |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Edessa
What we like
- Each product page carries a plain three-rung "PLAN / PER MONTH" table, so the commitment behind every figure is visible
- "Same price, every dose" is printed on each product page
- Names its operating entity and a full street address in Las Vegas, Nevada
- The program is stated as all-inclusive — provider consultation, medication, free expedited shipping, ongoing check-ins and 24/7 clinical support — and is HSA and FSA eligible
The caveats
- The homepage leads with "Start for just $135", which is a six-month prepay on the semaglutide injection; month-to-month tirzepatide is $239
- All three homepage cards quote the six-month rung, so the real monthly rates appear only after a click
- Its own Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation" — and an LLC is not a corporation
- "Join 100,000+ successful GLP-1 patients" carries no source, and the advertised money-back guarantee's terms are on no marketing page
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
A six-month committer, or anyone willing to click past the homepage to the table that states the real monthly rate.
Visit Edessa Read the full Edessa review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Edessa does the reverse.
More on CoreAge Rx
More on Edessa
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.